TREATMENT WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS: EFFICACY AND SAFETY OF CHANGEOVER

• Hoofdauteurs: A. A. Baranov (Auteur), E. I. Alexeeva (Auteur), S. I. Valieva (Auteur), T. M. Bzarova (Auteur), E. V. Mitenko (Auteur), R. V. Denisova (Auteur), A. N. Fetisova (Auteur), T. V. Sleptsova (Auteur), K. B. Isaeva (Auteur), E. G. Chistyakova (Auteur), N. I. Taibulatov (Auteur), A. M. Chomakhidze (Auteur)
• Formaat: Boek
• Gepubliceerd in: "Paediatrician" Publishers LLC, 2014-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Aim: to assess efficacy and safety of «changeover» to the second genetically engineered biological agent (GEBA) in patients with juvenile idiopathic arthritis (JIA) with resistance or intolerability to the first GEBA. Patients and methods: the results of retrospective observational research of effic...